What is Parallel Fluidics?
Parallel Fluidics is revolutionizing scientific research by providing the world's first on-demand microfluidic manufacturing service. Their innovative approach allows scientific teams to obtain production-grade microfluidic devices from the initial concept stage, thereby mitigating development risks and significantly shortening the time from idea to a functional product. This capability is particularly transformative across critical life sciences verticals, including diagnostics, drug discovery, precision medicine, sequencing, and cell therapy, empowering researchers to achieve breakthroughs more efficiently and improve patient outcomes.
How much funding has Parallel Fluidics raised?
Parallel Fluidics has raised a total of $8.8M across 2 funding rounds:
Unspecified
$1.8M
Angel/Seed
$7M
Unspecified (2021): $1.8M, investors not publicly disclosed
Angel/Seed (2024): $7M led by 8VC, Praxis, and J2 Ventures
Key Investors in Parallel Fluidics
8VC
8VC is a leading technology investment firm that backs visionary teams and industry-transforming companies, with a focus on smart enterprise platforms across various sectors including healthcare and Bio-IT.
J2 Ventures
J2 Ventures is an investment firm specializing in early-stage companies pioneering advanced technologies in biomedical engineering and other fields, leveraging their diverse expertise to support founder growth.
What's next for Parallel Fluidics?
With the recent major strategic investment, Parallel Fluidics is poised to scale its operations and further enhance its on-demand microfluidic manufacturing capabilities. This enterprise-level backing suggests a strategic focus on expanding market reach and deepening its impact within the life sciences ecosystem. The company is likely to invest in further technological advancements, potentially broadening its service offerings and solidifying its position as a key enabler of innovation for scientific discovery. The trajectory indicates a strong emphasis on accelerating the development cycle for complex microfluidic applications, driving forward advancements in healthcare and biotechnology.
See full Parallel Fluidics company page
